New recommendations outlined include advice for managing C. difficile infection in both community and hospital settings
News
New plans to improve patient access to mental health services unveiled in England
NHS England has set out new plans to introduce five new waiting time guarantees for mental health services
Seres’ ulcerative colitis candidate misses primary endpoint in mid-stage study
Microbiome-based therapeutic failed to improve clinical remission rates among mild-to-moderate ulcerative colitis patients
AZ says its COVID-19 vaccine protects against severe disease caused by variants
Real-world data shows jab is effective after one dose against hospitalisation/death caused by Beta and Delta variants
Nanopharm and Leyden Labs link up in nasal spray partnership
Partnership will aim to develop nasal spray drug products for prophylactic use against respiratory viruses
Albireo’s Bylvay approved in EU and US for rare paediatric liver disease
PFIC is a rare and progressive liver disease affecting young children which can lead to cirrhosis and liver failure
MSD, Bayer’s heart failure med Verquvo gains EU approval
Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction
NICE recommends Incyte’s Pemazyre for rare bile duct cancer
Pemazyre recommended for the treatment of cholangiocarcinoma, a rare type of liver cancer that forms in the bile duct
Gov’t reveals new strategy to improve support and care for autistic people
The Autism Strategy will be backed by nearly £75m in the first year, which includes £40m through the NHS Long Term Plan
Orbit Discovery raises $7.6m to boost peptide drug discovery services
The latest funding round was led by Oxford Sciences Innovation
Myovant, Gedeon Richter’s uterine fibroids med Ryeqo bags EU approval
EC has cleared Ryeqo for the treatment of moderate to severe symptoms of uterine fibroids
NHS England unveils new Innovative Medicine Fund
The new fund will build upon the Cancer Drugs Fund to fast-track access to promising new treatments
Celltrion says its COVID-19 antibody shows ‘strong neutralising activity’ against Delta variant
A therapeutic dose of regdanvimab also reduced the viral load of the SARS-CoV-2 virus and inflammation in the lungs
EU approval for self-administered Crysvita
Crysvita is used to treat the rare genetic condition X-linked hypophosphataemia
Roche reveals new safety data for haemophilia treatment Hemlibra
No new safety signals identified with longer-term Hemlibra treatment in adult and adolescent patients
